Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 536

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis

Open access
van der Hulle, T., Kooiman, J., den Exter, P.L., Dekkers, O.M., Klok, F.A., Huisman, M.V.·2014·Journal of Thrombosis and Haemostasis
DOI 10.1111/jth.12485
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jth.12485

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 24

  1. Hutten, 2006, Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism, Cochrane Database Syst Rev, CD001367
  2. Linkins, 2003, Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta‐analysis, Ann Intern Med, 139, 893, 10.7326/0003-4819-139-11-200312020-00007 · DOI · Paper page
  3. Douketis, 2000, Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy, Arch Intern Med, 160, 3431, 10.1001/archinte.160.22.3431 · DOI · Paper page
  4. Ahrens, 2010, New oral anticoagulant drugs in cardiovascular disease, Thromb Haemost, 104, 49, 10.1160/TH09-05-0327 · DOI · Paper page
  5. Schulman, 2009, Dabigatran versus warfarin in the treatment of acute venous thromboembolism, N Engl J Med, 361, 2342, 10.1056/NEJMoa0906598 · DOI · Paper page
  6. Buller, 2012, Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, N Engl J Med, 366, 1287, 10.1056/NEJMoa1113572 · DOI
  7. Huisman, 2013, Diagnostic management of acute deep vein thrombosis and pulmonary embolism, J Thromb Haemost, 11, 412, 10.1111/jth.12124 · DOI · Paper page
  8. Eriksson, 2003, A randomized, controlled, dose‐guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I, J Thromb Haemost, 1, 41, 10.1046/j.1538-7836.2003.00034.x · doi:10.1046/j.1538-7836.2003.00034.x
  9. Schulman, 2005, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients, J Thromb Haemost, 3, 692, 10.1111/j.1538-7836.2005.01204.x · DOI · Paper page
  10. Buller, 2007, Idraparinux versus standard therapy for venous thromboembolic disease, N Engl J Med, 357, 1094, 10.1056/NEJMoa064247 · DOI · Paper page
  11. Buller, 2008, Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study, J Thromb Haemost, 6, 1313, 10.1111/j.1538-7836.2008.03054.x · DOI · Paper page
  12. Wahlander, 2002, Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis, Thromb Res, 107, 93, 10.1016/S0049-3848(02)00259-1 · doi:10.1016/s0049-3848(02)00259-1
  13. Schulman, 2011, A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE‐COVER II), Blood (ASH Annual Meeting Abstracts), 118, 205
  14. Fiessinger, 2005, Ximelagatran vs low‐molecular‐weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial, JAMA, 293, 681, 10.1001/jama.293.6.681 · DOI · Paper page
  15. Schulman, 2003, Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran, N Engl J Med, 349, 1713, 10.1056/NEJMoa030104 · DOI · Paper page
  16. Agnelli, 2013, Oral apixaban for the treatment of acute venous thromboembolism, N Engl J Med, 369, 799, 10.1056/NEJMoa1302507 · DOI · Paper page
  17. Fox, 2012, Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta‐analysis of randomised controlled trials, BMJ, 345, e7498, 10.1136/bmj.e7498 · DOI
  18. Dale, 2013, Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?, J Thromb Thrombolysis, 35, 295, 10.1007/s11239-012-0857-9 · DOI
  19. Haas, 2009, Rivaroxaban – an oral, direct factor Xa inhibitor: lessons from a broad clinical study programme, Eur J Haematol, 82, 339, 10.1111/j.1600-0609.2009.01230.x · DOI
  20. Eerenberg, 2011, Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo‐controlled, crossover study in healthy subjects, Circulation, 124, 1573, 10.1161/CIRCULATIONAHA.111.029017 · DOI · Paper page
  21. Weitz, 2012, Periprocedural management and approach to bleeding in patients taking dabigatran, Circulation, 126, 2428, 10.1161/CIRCULATIONAHA.112.123224 · DOI
  22. Majeed, 2013, Management and outcomes of major bleeding during treatment with dabigatran or warfarin, Circulation, 128, 2325, 10.1161/CIRCULATIONAHA.113.002332 · DOI · Paper page
  23. Lega, 2013, Impact of double‐blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta‐analysis, J Thromb Haemost, 11, 1240, 10.1111/jth.12294 · DOI
  24. O'Neil, 2013, Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double‐blind conditions?, Thromb Haemost, 109, 497, 10.1160/TH12-10-0715 · DOI

Cited by

See all 536

Metadata

Authors
van der Hulle, T., Kooiman, J., den Exter, P. L., Dekkers, O. M., Klok, F. A., & Huisman, M. V.
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2014-03
Volume
12
Issue
3
Pages
320-328
ISSN
1538-7836 (ISSN-L)
DOI
10.1111/jth.12485
OpenAlex
W2113561246
Cited by
536
References
7
FWCI
8.90
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/jth.12485
The paper
van der Hulle, T., Kooiman, J., den Exter, P. L., Dekkers, O. M., Klok, F. A., & Huisman, M. V. (2014). Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.12485

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.